Allschwil-based Idorsia has granted Jamjoom Pharma exclusive rights to distribute and commercialise its insomnia treatment QUVIVIQ in Saudi Arabia and the Levant. It is the company's second Middle ...
ZuriQ has raised USD 25.5 million in a seed round to scale the trapped-ion quantum processors it is building on a two-dimensional chip architecture. The round was led by Quantonation, and includes ...
Zurich-based BLP Digital, which automates enterprise resource planning processes with AI agents, already counts more than 450 corporate customers in over 40 countries. The main reasons for the ...
🚀 Startups, take note! Are you looking for investors for your next funding round? 👉 Now is your chance! 🎤 Pitch at StartAngels in collaboration with Rahn+Bodmer Co. On June 23, 2026, selected ...
The seven-figure pre-seed round drew several VC offices and angel investor: xdeck, HEARTFELT_, OMA Business Angels, superangels, Prequel Ventures and PRXS Technology and Investment, together with ...
Geneva-based Colb Asset SA, focussed on real-world asset tokenization, has closed an oversubscribed CHF 6 million seed extension round. The investment comes from a private investor overseeing over $20 ...
NYU Grossman School of Medicine is the first clinical site to participate in the SHIELD study, giving the company the opportunity to evaluate VENUS SHELLâ„¢ in a leading radiation oncology center in the ...
Arcoris bio has signed a distribution agreement to take its biomarker-detection kits into Europe and North America, Hi-D Imaging has secured expanded FDA clearance for its AI-driven heart-valve ...
AI connectivity specialist Kandou AI is opening a chip design headquarters in Hyderabad, India. Meanwhile, Bitcoin Suisse has obtained financial services permission to begin its expansion into the ...
Hilo, a health technology brand developed by Aktiia, has launched Hilo Core, a first-of-its-kind system designed to deliver long-term blood pressure insights and empower individuals to better ...
Cliramitug is an investigational human monoclonal antibody discovered by Neurimmune and designed to deplete amyloid deposits from affected hearts in patients with amyloid transthy ...
MoleSense is developing a Wear & Forget platform for continuous hormone monitoring that unifies ultra-low-power on-demand sedentary sweat extraction with aptamer-based multi-hormone nanobiosensing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results